From the Maryland Department of Health (MDH): Urgent Provider Alert regarding the bicillin shortage (syphilis treatment) anticipated to last through Apr-June, 2024
Posted about 2 years ago by Elaine Crain
This announcement has 1 attachment:
See attached provider alert about a critical shortage of bicillin, which is anticipated to become a full depletion of stock by the manufacturer, Pfizer. The "stock-out" is not anticipated to be resolved until sometime during the second quarter of 2024. In the MDH Alert, which may not have been received by all RN/CNM/NPs, we provide CDC guidance on preserving inventory for treatment of pregnant patients with syphilis, and for neonates with congenital syphilis. Additionally, we encourage clinicians to call local health departments or us at the state, for assistance with patient testing and treatment information and for help getting pregnant patients treated if providers don't stock bicillin or have run out.
Elisabeth Liebow, MPH
Chief, Division of Policy, Planning and Communication
Center for STI Prevention
Infectious Disease Prevention and Health Services Bureau
Maryland Department of Health (MDH)
1223 W. Pratt Street, Baltimore MD 21223
Work Cell: 443.955.0362 / Office: 410-767-5160 / Fax: 410-528-6098
MDH is committed to customer service. Click here to take the Customer Satisfaction Survey.